SGLT‑2 Inhibitors and GLP‑1 Agonists for T2DM: Prescribing Considerations for Community Pharmacists
Wednesday June 7, 2023
Presented by Dalhousie University Academic Detailing
Register for the RECORDING
This webinar is accredited for 1.0 CEU
and is valid until June 6, 2024
This presentation will summarize evidence evaluating clinical efficacy and potential harms of SGLT-2 Inhibitors and GLP-1 Agonists in the treatment of T2DM.
Participants will learn key evidence-based prescribing pearls and of potential adverse effects and drug interactions that may occur with the use of these medications and mitigation strategies to reduce harm.
Join our email list to be the first to know to about upcoming live webinars!